Halozyme Therapeutics (HALO) Announces Baxter (BAX) Received FDA Complete Response Letter For HyQ BLA
Go back to Halozyme Therapeutics (HALO) Announces Baxter (BAX) Received FDA Complete Response Letter For HyQ BLA| Baxter International Inc. (NYSE: BAX) | Delayed: 25.94 +0.03 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.91 | 52 Week High | $50.16 | |||
| Open | $26.08 | 52 Week Low | $34.06 | |||
| Day High | $26.34 | P/E | 7.09 | |||
| Day Low | $25.75 | EPS | $3.66 | |||
| Volume | 6,656,363 | |||||
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 104.89 +1.89 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.00 | 52 Week High | $18.39 | |||
| Open | $102.95 | 52 Week Low | $6.96 | |||
| Day High | $105.11 | P/E | N/A | |||
| Day Low | $102.39 | EPS | $-0.58 | |||
| Volume | 1,951,987 | |||||
